CClinicalTrials.gg
Active, not recruitingNCT07172399Updated Sep 15, 2025

Factors Associated With Pre-hypertension Among Children With Type 1 Diabetes Mellitus

An observational study in Hypertension, sponsored by Sohag University. Active, not recruiting at 1 site in Egypt. Open to participants aged 6 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-15.

Sponsored by Sohag University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
60
Ages
6 Years to 18 Years
Sex
All
01

Study summary

blood pressure of diabetic patients will be measured

Read the detailed description

All the study participants will be examined for assessment of the height and weight using calibrated equipment, Body Mass Index (BMI) calculated and plotted against percentiles,Blood Pressure (BP) Measurement:

  • BP will be measured using a calibrated, automated oscillometric device suitable for pediatric use.
  • Appropriate cuff size will be used based on mid-arm circumference.
  • Blood pressure will be measured in the non-dominant arm.
  • BP will be measured three times on at least two different occasions, after 5 minutes of rest, in a seated position.
  • The average of the readings will be recorded.
02

Conditions studied

  • Hypertension

Browse trials for

03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's planned enrollment of 60 is below the median of 210 across 1,359 observational studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

cildren from 6 to 18 year old

Inclusion criteria

  • Children and adolescents aged 6 - 18 years, diagnosed with T1DM for at least 1 year and attending the Pediatric diabetes clinic at Sohag University Hospital will be included as cases.

Exclusion criteria

Exclusion Criteria:

Children and adolescents with T1DM associated with autoimmune hypothyroidism or celiac disease and those who had received any form of corticosteroids therapy for any reason in the last 6 months will be excluded.

-

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
60 participants (estimated)
Target follow-up
10 Months
Patient registry
Yes
Biospecimen retention
Samples without dna

Interventions

  • Procedureblood sampling

    blood samples will be taken to discover if there is hyperlipedemia,hyperthrodism or acute kidney injury

  • Other• BP will be measured using a calibrated, automated oscillometric device suitable for pediatric use.

    All the study participants will be examined for assessment of the height and weight using calibrated equipment, Body Mass Index ,blood pressure will be measured.

06

What researchers measure

Primary outcomes

  1. blood pressure

    * BP will be measured using a calibrated, automated oscillometric device suitable for pediatric use. * Appropriate cuff size will be used based on mid-arm circumference. * Blood pressure will be measured in the non-dominant arm. * BP will be measured three times on at least two different occasions, after 5 minutes of rest, in a seated position. * The average of the readings will be recorded * BP will be measured using a calibrated, automated oscillometric device suitable for pediatric use. * Appropriate cuff size will be used based on mid-arm circumference. * Blood pressure will be measured in the non-dominant arm. * BP will be measured three times on at least two different occasions, after 5 minutes of rest, in a seated position. * The average of the readings will be recorded * BP will be measured using a calibrated, automated oscillometric device suitable for pediatric

    Time frame: one year

07

Study locations

1 site
  • Sohag university hospital
    Sohag, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07172399
Lead sponsor
Sohag University
Responsible party
Aya Mohamed Ibrahim (aya ibrahim, Sohag University) — Principal investigator
First posted
Sep 15, 2025
Start date
Jul 26, 2025
Primary completion
Jul 25, 2026 (estimated)
Completion
Aug 5, 2026 (estimated)
Last update
Sep 15, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion